Mawallafi: Gregory Harris
Ranar Halitta: 14 Afrilu 2021
Sabuntawa: 18 Nuwamba 2024
Anonim
Mode of action of Saccharomyces boulardii CNCM I-745
Video: Mode of action of Saccharomyces boulardii CNCM I-745

Wadatacce

Saccharomyces boulardii shine yisti. An gano shi a baya azaman nau'in yisti na musamman. Yanzu an yi imanin cewa ƙwayar cuta ce ta Saccharomyces cerevisiae. Amma Saccharomyces boulardii ya bambanta da sauran nau'o'in Saccharomyces cerevisiae wanda aka fi sani da yisti na brewer da yisti mai burodi. Ana amfani da Saccharomyces boulardii a matsayin magani.

Ana amfani da Saccharomyces boulardii mafi yawa don magancewa da hana gudawa, gami da nau'ikan cututtuka kamar zazzabin rotaviral a cikin yara. Yana da wasu shaidar amfani ga wasu nau'ikan gudawa, kuraje, da cututtukan ƙwayar narkewa wanda zai haifar da ulcers.

Ciwon kwayar cutar Coronavirus 2019 (COVID-19): Babu kyakkyawar shaida don tallafawa ta amfani da Saccharomyces boulardii don COVID-19. Bi zaɓin rayuwa mai kyau da ingantattun hanyoyin rigakafin maimakon.

Magunguna na Compwararren Bayanan Bayanai ƙimar tasiri bisa ga shaidar kimiyya bisa ga mizani mai zuwa: Inganci, Mai yuwuwa Mai Yiwuwa, Yiwuwar Tasiri, Yiwuwar Mara Inganci, Mai yiwuwa Mara Inganci, Mara Inganci, da suarancin Shaida don Rate.

Effectivenessimar tasiri don SACCHAROMYCES BOULARDII sune kamar haka:


Da alama tasiri ga ...

  • Gudawa. Bincike ya nuna cewa baiwa yara masu cutar gudawa ta Saccharomyces boulardii na iya rage tsawon lokacin da zai kwashe har zuwa kwana 1. Amma Saccharomyces boulardii da alama ba shi da tasiri sosai fiye da magunguna na al'ada don gudawa, kamar loperamide (Imodium).
  • Gudawa da cutar rotavirus ta haddasa. Bada Saccharomyces boulardii ga jarirai da yara masu gudawa sanadiyyar rotavirus zai iya rage tsawon lokacin gudawa na tsawan kwana 1.

Yiwuwar tasiri ga ...

  • Kuraje. Bincike ya nuna cewa shan Saccharomyces boulardii da baki yana taimakawa wajen inganta bayyanar cututtukan fata.
  • Gudawa a cikin mutanen da ke shan maganin rigakafi (cututtukan da ke hade da kwayoyin cuta). Mafi yawan bincike ya nuna cewa Saccharomyces boulardii na iya taimakawa wajen hana gudawa a cikin manya da yara ana ba su maganin rigakafi. Ga kowane marasa lafiya na 9-13 da aka yiwa magani tare da Saccharomyces boulardii yayin magani tare da maganin rigakafi, ƙaramin mutum zai kamu da gudawa da ke da alaƙa da kwayoyin.
  • Kamuwa da cututtukan ciki ta hanyar ƙwayoyin cuta da ake kira Clostridium wuya. Shan Saccharomyces boulardii tare da maganin rigakafi da alama zai taimaka hana rigakafin cututtukan Clostridium mai alaƙa da sake faruwa a cikin mutane tare da tarihin sake dawowa. Shan saccharomyces boulardii tare da maganin rigakafi shima yana taimakawa wajen hana aukuwa na farko na cutar gudawa mai hade da Clostridium. Amma masana ba da shawarar yin amfani da Saccharomyces don hana abubuwan farko ba.
  • Cututtuka na narkewa wanda zai haifar da ulcers (Helicobacter pylori ko H. pylori). Shan Saccharomyces boulardii ta baki tare da daidaitaccen magani H. pylori yana taimakawa magance wannan kamuwa da cutar. Kimanin mutane 12 suke buƙatar a yi musu magani tare da ƙarin Saccharomyces boulardii ga mai haƙuri guda ɗaya wanda in ba haka ba zai ci gaba da kamuwa da cutar ba. Shan Saccharomyces boulardii shima yana taimakawa wajen kiyaye illa kamar gudawa da tashin zuciya da ke faruwa tare da daidaitaccen maganin H. pylori. Wannan na iya taimaka wa mutane su gama daidaitaccen maganin su na H. pylori.
  • Gudawa a cikin mutanen da ke ɗauke da cutar HIV / AIDS. Shan Saccharomyces boulardii ta baki yana rage rage gudawa mai nasaba da kwayar HIV.
  • Cutar mai tsanani a cikin jarirai wanda bai isa haihuwa ba (necrotizing enterocolitis ko NEC). Mafi yawan bincike ya nuna cewa baiwa Saccharomyces boulardii ga jarirai kafin lokacin haihuwa ya hana NEC.
  • Gudawar matafiya. Shan Saccharomyces boulardii ta baki yana bayyana don hana zawowar matafiya.

Zai yuwu bashi da tasiri ga ...

  • Ciwon jini (sepsis). Bincike ya nuna cewa bayar da Saccharomyces boulardii ga jarirai kafin lokacin haihuwa baya hana sepsis.

Evidencearancin shaida don kimanta inganci don ...

  • Kamuwa da cuta daga hanji wanda ke haifar da gudawa (kwalara). Saccharomyces boulardii ba ze inganta alamun kwalara ba, koda lokacin da aka bashi da daidaitaccen magani.
  • Memwaƙwalwar ajiya da ƙwarewar tunani (aikin fahimi). Binciken farko ya nuna cewa shan Saccharomyces boulardii ba ya taimaka wa ɗalibai yin kyau a kan jarabawa ko rage damuwar su.
  • Wani nau'in cututtukan hanji mai kumburi (cutar Crohn). Shan Saccharomyces boulardii da alama yana rage yawan motsin hanji a cikin mutane masu cutar Crohn. Binciken farko ya kuma nuna cewa shan Saccharomyces boulardii tare da mesalamine na iya taimaka wa mutanen da ke dauke da cutar Crohn su kasance cikin gafartawa tsawon lokaci. Amma shan Saccharomyces boulardii shi kadai ba ze taimakawa mutanen da ke dauke da cutar ta Crohn ba har abada.
  • Cystic fibrosis. Binciken farko ya nuna cewa shan Saccharomyces boulardii ta baki ba zai rage cututtukan yisti a cikin hanyar narkewar abinci na mutanen da ke fama da cutar cystic fibrosis.
  • Ajiyar zuciya. Binciken farko ya nuna cewa shan Saccharomyces boulardii na iya inganta aikin zuciya ga mutanen da ke fama da ciwon zuciya.
  • Babban cholesterol. Binciken farko ya nuna cewa Saccharomyces boulardii ba ze iya shafar matakan cholesterol.
  • Rashin lafiya na dogon lokaci na manyan hanji wanda ke haifar da ciwon ciki (ciwon mara na hanji ko IBS). Bincike ya nuna cewa shan Saccharomyces boulardii na inganta ingancin rayuwa ga mutanen da ke fama da gudawa-yawanci ko nau'ikan nau'ikan IBS. Amma Saccharomyces boulardii ba ze inganta yawancin alamun IBS irin su ciwon ciki, gaggawa, ko kumburi.
  • Cutar cututtukan hanji ta ƙwayoyin cuta. Binciken farko ya nuna cewa shan Saccharomyces boulardii ta baki tare da maganin rigakafi na rage gudawa da ciwon ciki ga mutanen da ke fama da cututtukan amoeba.
  • Yellowing na fata a cikin jarirai (jariri neonatal). Wasu jarirai suna kamuwa da cutar jaundice bayan haihuwa saboda yawan bilirubin. Bada Saccharomyces boulardii don yiwa jarirai lafazin na iya hana cutar jaundice da kuma rage bukatar maganin foterapi a karamin adadin wadannan jarirai. Amma ba a san idan Saccharomyces boulardii ya rage haɗarin cutar cizon sauro a cikin jarirai masu haɗari ba. Ba da kyautar Saccharomyces boulardii ga jarirai tare da maganin ƙwaƙwalwar ajiya ba ya rage matakan bilirubin da ya fi phototherapy shi kaɗai.
  • Yaran da aka haifa nauyinsu bai wuce gram 2500 ba (fam 5, auduga 8). Ba da ƙarin Sacouromyces boulardii bayan haihuwa alama ce ta haɓaka ƙimar kiba da ciyarwa a cikin jarirai masu haihuwa da ƙananan nauyin haihuwa.
  • Yawan ƙwayoyin cuta a cikin ƙananan hanji. Binciken farko ya nuna cewa kara Saccharomyces boulardii don magani tare da maganin rigakafi yana rage ci gaban kwayoyin cuta a cikin hanji mafi kyau fiye da maganin rigakafi kadai.
  • Wani nau'in cututtukan hanji mai kumburi (ulcerative colitis). Binciken farko ya nuna cewa ƙara Saccharomyces boulardii zuwa daidaitaccen maganin mesalamine na iya rage alamomi a cikin mutanen da ke fama da ciwon ulcerative ulitis.
  • Ciwon kankara.
  • Zazzaɓin zazzaɓi.
  • Kyauta.
  • Rashin haƙuri na Lactose.
  • Cutar Lyme.
  • Ciwon jijiyoyin jiki da motsa jiki ya haifar.
  • Cututtukan fitsari (UTIs).
  • Yisti cututtuka.
  • Sauran yanayi.
Ana buƙatar ƙarin shaida don kimanta Saccharomyces boulardii don waɗannan amfanin.

Ana kiran Saccharomyces boulardii da "probiotic," kwayar abota wacce ke taimakawa wajen yakar kwayoyin cututtukan cikin hanji kamar kwayoyin cuta da yisti.

Lokacin shan ta bakin: Saccharomyces boulardii ne LAFIYA LAFIYA ga mafi yawan manya idan aka sha su da baki har tsawon watanni 15. Yana iya haifar da gas a cikin wasu mutane. Ba da daɗewa ba, zai iya haifar da cututtukan fungal waɗanda za su iya yaɗuwa ta hanyoyin jini zuwa cikin jiki duka (fungemia).

Kariya & Gargaɗi na Musamman:

Ciki da shan nono: Babu isasshen bayani tabbatacce don sanin idan Saccharomyces boulardii yana da aminci don amfani lokacin da mai ciki ko ciyar da nono. Kasance a gefen aminci ka guji amfani.

Yara: Saccharomyces boulardii ne MALAM LAFIYA ga yara lokacin da aka ɗauke ta bakin da ta dace. Koyaya, zazzabin cikin yara yakamata a kimanta shi ta hanyar masanin kiwon lafiya kafin amfani da Saccharomyces boulardii.

Tsofaffi: Tsofaffi na iya ƙara haɗarin kamuwa da fungal yayin shan Saccharomyces boulardii. Kasance a gefen aminci ka guji amfani.

Karfin garkuwar jiki: Akwai wata damuwa cewa shan Saccharomyces boulardii na iya haifar da fungemia, wanda shine kasancewar yisti a cikin jini. Ainihin adadin shari'o'in Saccharomyces boulardii da ke da alaƙa da fungemia yana da wuyar tantancewa. Koyaya, haɗarin yana da girma ga mutanen da ke rashin lafiya sosai ko waɗanda suka raunana tsarin garkuwar jiki. Musamman, mutanen da ke da catheters, waɗanda ke karɓar abincin bututu, da waɗanda ake kula da su tare da magungunan rigakafi da yawa ko magungunan rigakafi da ke aiki a kan cututtuka iri-iri da alama suna da haɗari. A lokuta da yawa, fungemia na haifar da gurɓatar catheter ta iska, saman muhalli, ko hannayen da aka gurɓata da Saccharomyces boulardii.

Yisti rashin lafiyan: Mutane masu cutar rashin yisti na iya zama masu rashin lafiyan kayan da ke dauke da Saccharomyces boulardii, kuma an fi ba su shawara su guji waɗannan kayan.

Orananan
Yi hankali da wannan haɗin.
Magunguna don cututtukan fungal (Antifungals)
Saccharomyces boulardii shine naman gwari. Magunguna don cututtukan fungal suna taimakawa rage naman gwari a ciki da jiki. Shan Saccharomyces boulardii tare da magunguna don cututtukan fungal na iya rage tasirin Saccharomyces boulardii.
Wasu magunguna don kamuwa da fungal sun haɗa da fluconazole (Diflucan), caspofungin (Cancidas), itraconazole (Sporanox) amphotericin (Ambisome), da sauransu.
Babu sanannun hulɗa tare da ganye da kari.
Babu sanannun hulɗa da abinci.
An yi nazarin ƙwayoyi masu zuwa a cikin binciken kimiyya:

MAGABATA

TA BAKI:
  • Don gudawa a cikin mutanen da ke shan maganin rigakafi (cututtukan da ke hade da kwayoyin cuta): 250-500 MG na Saccharomyces boulardii da aka sha sau 2-4 kowace rana har zuwa makonni 2 anfi amfani dashi. A mafi yawan lokuta, allurar yau da kullun bata wuce 1000 MG kowace rana.
  • Don kamuwa da cututtukan ciki da ake kira Clostridium wuya: Don hana sake dawowa, MG 500 na Saccharomyces boulardii sau biyu kowace rana don makonni 4 tare da amfani da maganin rigakafi.
  • Don cututtukan ƙwayar narkewa wanda zai haifar da ulcers (Helicobacter pylori ko H. pylori): 500-1000 MG na Saccharomyces boulardii kowace rana don makonni 1-4 anfi amfani dashi.
  • Don gudawa a cikin mutanen da ke ɗauke da cutar HIV / AIDS: Gram 3 na Saccharomyces boulardii kowace rana.
  • Ga gudawa na matafiya: 250-1000 MG na Saccharomyces boulardii kowace rana don wata 1.
YARA

TA BAKI:
  • Don gudawa a cikin mutanen da ke shan maganin rigakafi (cututtukan da ke hade da kwayoyin cuta): 250 MG na Saccharomyces boulardii sau ɗaya ko sau biyu a rana don tsawon lokacin amfani da maganin rigakafi.
  • Ga gudawa: Don magance cutar gudawa, an yi amfani da MG 250 na Saccharomyces boulardii sau ɗaya ko sau biyu a kowace rana ko kuma rukunin masu mallaka miliyan dubu 10 sau ɗaya a rana tsawon kwanaki 5. Don magance cutar gudawa mai ci gaba, ana amfani da raka'a biliyan 1750 zuwa tiriliyan 175 na Saccharomyces boulardii sau biyu a rana don kwanaki 5. Don hana gudawa a cikin mutanen da ke karɓar abincin bututu, an yi amfani da MG 500 na Saccharomyces boulardii sau huɗu a rana.
  • Ga gudawa da rotavirus ke haifarwa: An yi amfani da 200-250 mg na Saccharomyces boulardii sau biyu a rana don kwanaki 5.
  • Don mummunan cututtukan hanji a cikin jarirai wanda bai kai ba (necrotizing enterocolitis ko NEC): 100-200 mg / kg Saccharomyces boulardii kowace rana, farawa makon farko bayan haihuwa.
Probiotic, Probiotique, Saccharomyces, Saccharomyces Boulardii CNCM I-745; Cerevisiae HANSEN CBS 5926, Saccharomyces cerevisiae var boulardii, S. Boulardii, SCB.

Don ƙarin koyo game da yadda aka rubuta wannan labarin, da fatan za a duba Magunguna na Compwararren Bayanan Bayanai hanya.


  1. ID na Florez, Veroniki AA, Al Khalifah R, et al. Ingantaccen tasiri da amincin maganganu don cutar gudawa da cututtukan ciki a cikin yara: Nazarin tsari da hanyar sadarwar meta. Koma Daya. 2018; 13: e0207701. Duba m.
  2. Harnett JE, Pyne DB, McKune AJ, Penm J, Pumpa KL. Proarin kwayar halitta yana haifar da canje-canje masu dacewa a cikin ciwon tsoka da ƙimar bacci a cikin 'yan wasan rugby. J Sci Med Wasanni. 2020: S1440-244030737-4. Duba m.
  3. Gao X, Wang Y, Shi L, Feng W, Yi K. Amfani da amincin Saccharomyces boulardii don ƙananan ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta a cikin jarirai kafin lokacin: Nazarin tsari da meta-bincike. J Trop Pediatr. 2020: fmaa022. Duba m.
  4. Mourey F, Sureja V, Kheni D, et al. Masana da yawa, bazuwar, makafi biyu, gwajin sarrafa wuribo na Saccharomyces boulardii a cikin jarirai da yara masu fama da cutar gudawa. Ciwon Pediatr Infect Dis J. 2020; 39: e347-e351. Duba m.
  5. Karbownik MS, Kr & eogon; czy & nacute; ska J, Kwarta P, et al. Amfani da kari tare da Saccharomyces boulardii kan aikin gwajin ilimi da damuwa mai alaƙa a cikin ɗaliban likitocin lafiya: Bazuwar, makafi biyu, gwajin sarrafa wuribo. Kayan abinci. 2020; 12: 1469. Duba m.
  6. Zhou BG, Chen LX, Li B, Wan LY, Ai YW. Saccharomyces boulardii a matsayin maganin adjuvant don kawar da Helicobacter pylori: Bincike na yau da kullun da zane-zane tare da binciken gwaji na gaba. Helicobacter. 2019; 24: e12651. Duba m.
  7. Szajewska H, ​​Kolodziej M, Zalewski BM. Bincike na yau da kullun tare da zane-zane: Saccharomyces boulardii don magance mummunan ciwon ciki a cikin yara-sabuntawa na 2020. Aliment Pharmacol Ther. 2020. Duba m.
  8. Seddik H, Boutallaka H, ​​Elkoti I, et al. Saccharomyces boulardii CNCM I-745 tare da daidaitaccen magani don cututtukan Helicobacter pylori: gwajin bazuwar, lakabin buɗaɗɗe. Eur J Clin Pharmacol. 2019; 75: 639-645. Duba m.
  9. García-Collinot G, Madrigal-Santillán EO, Martínez-Bencomo MA, et al. Ingancin Saccharomyces boulardii da Metronidazole don Intananan Ciwon Bacwayar Cutar Cikin Tsarin Sclerosis .Dig Dis Sci. 2019. Duba m.
  10. McDonald LC, Gerding DN, Johnson S, et al.; Diseungiyar Cututtuka na Cututtuka na Amurka. Ka'idojin aikin asibiti don kamuwa da cutar Clostridium mai wahala a cikin manya da yara: sabuntawa na 2017 ta Societyungiyar Cututtukan Cututtuka na Amurka (IDSA) da ofungiyar Kula da Kiwon Lafiyar Kiwon Lafiya ta Amurka (SHEA). Cututtukan Cututtuka na Clinical 2018; 66: e1-e48.
  11. Xu L, Wang Y, Wang Y, et al. Gwajin da bazuwar gwaji sau biyu akan ci gaba da haƙuri tare da Saccharomyces boulardii CNCM I-745 a cikin ƙananan yara masu ƙarancin ciki. J Pediatr (Rio J). 2016; 92: 296-301. Duba m.
  12. Sheele J, Cartowski J, Dart A, et al. Saccharomyces boulardii da bismuth subsalicylate a matsayin ayyukan tsada mai sauki don rage tsawon lokaci da tsananin cutar kwalara. Pathog Global Lafiya. 2015; 109: 275-82. Duba m.
  13. Ryan JJ, Hanes DA, Schafer MB, Mikolai J, Zwickey H. Sakamakon Probiotic Saccharomyces boulardii akan ƙwayoyin Cholesterol da Lipoprotein a cikin Manyan Hypercholesterolemic: Singleaya-Arm, Binciken Buɗe-Label. J madadin Karin Med. 2015; 21: 288-93. Duba m.
  14. Flatley EA, Wilde AM, Nailor MD. Saccharomyces boulardii don rigakafin asibiti fara Clostridium mai wahala kamuwa da cuta. J Gastrointestin Hanta Dis. 2015; 24: 21-4. Duba m.
  15. Ehrhardt S, Guo N, Hinz R, et al. Saccharomyces boulardii don hana Cutar Kwayar Cutar Antibiotic-Associated: Cutar da bazuwarta, Maska biyu-biyu, Gwajin wuribo. Open Forum Infect Dis. 2016; 3: na na011. Duba m.
  16. Dinleyici EC, Kara A, Dalgic N, et al. Saccharomyces boulardii CNCM I-745 yana rage tsawon lokacin gudawa, tsawon kulawar gaggawa da kuma zaman asibiti a cikin yara masu fama da cutar gudawa. Fananan Microbes. 2015; 6: 415-21. Duba m.
  17. Dauby N. Risks of Saccharomyces boulardii-Dauke da Probiotics don Rigakafin Clostridium mai saurin Kamuwa da cuta a cikin Tsofaffi. Gastroenterology. 2017; 153: 1450-1451. Duba m.
  18. Cottrell J, Koenig K, Perfekt R, Hofmann R; Loperamide-Simethicone Studyungiyar Nazarin Cutar Gudawa. Kwatanta nau'i biyu na Loperamide-Simethicone da Yisti na Probiotic (Saccharomyces boulardii) a cikin Jiyya na Ciwon Cutar Gudawa a cikin Manya: Gwajin Rashin Ciwon Mara Inganci. Magunguna R D. 2015; 15: 363-73. Duba m.
  19. Costanza AC, Moscavitch SD, Faria Neto HC, Mesquita ET. Magungunan maganin rigakafi tare da Saccharomyces boulardii don marasa lafiya marasa lafiya: bazuwar, makafi biyu, gwajin gwajin wuribo. Int J Cardiol. 2015; 179: 348-50. Duba m.
  20. Carstensen JW, Chehri M, Schønning K, et al. Amfani da prophylactic Saccharomyces boulardii don hana kamuwa da cutar Clostridium a cikin marasa lafiya na asibiti: binciken sa ido mai yiwuwa shiga. Eur J Clin Microbiol mai cutar Dis. 2018; 37: 1431-1439. Duba m.
  21. Asmat S, Shaukat F, Asmat R, Bakhat HFSG, Asmat TM. Kwatancen Ingancin Ingancin Clinical na Saccharomyces Boulardii da Lactic Acid azaman Probiotics a Ciwon Cutar Ciwon Cutar Yara. J Coll Likitocin Surg Pak. 2018; 28: 214-217. Duba m.
  22. Remenova T, Morand O, Amato D, Chadha-Boreham H, Tsurutani S, Marquardt T. Wani makafi guda biyu, bazuwar, gwajin gwajin wuribo wanda ke nazarin tasirin Saccharomyces boulardii akan haƙuri na ciki, aminci, da magunguna na miglustat. Marayu J Rare Dis 2015; 10: 81. Duba m.
  23. Suganthi V, Das AG. Matsayi na Saccharomyces boulardii a rage haɓakar hyperbilirubinemia na jarirai. J Jarin Diagn Sakamakon 2016; 10: SC12-SC15. Duba m.
  24. Riaz M, Alam S, Malik A, Ali SM. Inganci da amincin Saccharomyces boulardii a cikin cutar gudawa mai ƙuruciya: gwajin makafi biyu da bazuwar gani. Indiya J Pediatr 2012; 79: 478-82. Duba m.
  25. - Corrêa NB, Penna FJ, Lima FM, Nicoli JR, Filho LA. Maganin zawo mai saurin gaske tare da Saccharomyces boulardii a jarirai. J Pediatr Gastroenterol Nutr 2011; 53: 497-501. Duba m.
  26. Cohen SH, Gerding DN, Johnson S, et al.; Forungiyar Kula da Kiwon Lafiyar Jama'a ta Amurka; Diseungiyar Cututtukan Cututtuka na Amurka. Ka'idojin aikin asibiti don kamuwa da cutar Clostridium mai wahala a cikin manya: 2010 sabuntawa ta al'umma don kiwon lafiya epidemiology na Amurka (SHEA) da cututtukan cututtukan jama'a na Amurka (IDSA). Asibitin Kula da Cututtuka na Cutar 2010; 31: 431-55. Duba m.
  27. Goldenberg JZ, Ma SS, Saxton JD, et al. Magungunan rigakafi don rigakafin cututtukan cututtukan Clostridium mai haɗari a cikin manya da yara. Cochrane Database Syst Rev. 2013;: CD006095. Duba m.
  28. Lau CS, Chamberlain RS. Magungunan rigakafi suna da tasiri wajen hana gudawa mai alaƙa da Clostridium mai wuya: nazari na yau da kullun da meta-bincike. Int J Gen Med. 2016; 9: 27-37. Duba m.
  29. Roy U, Jessani LG, Rudramurthy SM, et al. Abubuwa bakwai na Saccharomyces fungaemia masu alaƙa da amfani da maganin rigakafi. Magunguna 2017; 60: 375-380. Duba m.
  30. Romanio MR, Coraine LA, Maielo VP, Abramczyc ML, Souza RL, Oliveira NF.Saccharomyces cerevisiae fungemia a cikin haƙuri na yara bayan jiyya tare da maganin rigakafi. Rev Paul Pediatr 2017; 35: 361-4. Duba m.
  31. Pozzoni P, Riva A, Bellatorre AG, et al. Saccharomyces boulardii don rigakafin cututtukan da ke tattare da kwayoyin cuta a cikin tsofaffin marasa lafiya da ke asibiti: cibiya guda, bazuwar, makafi biyu, gwajin sarrafa wuribo. Am J Gastroenterol 2012; 107: 922-31. Duba m.
  32. Martin IW, Tonner R, Trivedi J, et al. Saccharomyces boulardii probiotic-hade fungemia: tambayar amincin wannan maganin rigakafin amfani. Diagn Microbiol mai cutar Dis. 2017; 87: 286-8. Duba m.
  33. Choi CH, Jo SY, Park HJ, Chang SK, Byeon JS, Myung SJ. Randomarƙwarar, makafi biyu, gwajin gwaji da wuri mai yawa na Saccharomyces boulardii a cikin cututtukan hanji mai haɗari: sakamako akan ingancin rayuwa. J Gastroenterol. 2011; 45: 679-83. Duba m.
  34. Atici S, Soysal A, Karadeniz Cerit K, et al. Abubuwan da ke da alaƙa da Saccharomyces cerevisiae Fungemia Bayan bin Saccharomyces boulardii Probiotic Jiyya: A cikin yaro a cikin sashin kulawa mai ƙarfi da nazarin littattafai. Maganar Med Mycol Case Rep. 2017; 15: 33-35. Duba m.
  35. Appel-da-Silva MC, Narvaez GA, Perez LRR, Drehmer L, Lewgoy J. Saccharomyces cerevisiae var. boulardii fungemia bayan maganin probiotic. Matsayi na Mycol Case Rep. 2017; 18: 15-7. Duba m.
  36. Chang HY, Chen JH, Chang JH, Lin HC, Lin CY, Peng CC. Magungunan maganin rigakafi da yawa sun zama mafi ingancin maganin rigakafin rigakafin cutar necrotizing enterocolitis da mace-mace: An sabunta meta-bincike. Koma Daya. 2017; 12: e0171579. Duba m.
  37. Blaabjerg S, Artzi DM, Aabenhus R. Magungunan rigakafi don Rigakafin cututtukan rigakafin rigakafin cututtukan rigakafi a cikin marasa lafiya - Nazarin Tsaro da Meta-Analysis. Magungunan rigakafi (Basel). 2017; 6. Duba m.
  38. Al Faleh K, Anabrees J. Probiotics don rigakafin necrotizing enterocolitis a cikin yara mata masu zuwa. Cochrane Database Syst Rev. 2014;: CD005496. Duba m.
  39. Das S, Gupta PK, Das RR. Inganci da Tsaron Saccharomyces boulardii a Ciwon Cutar Rota na Cutar Ruta: Ciwon Makafi Biyu Da Aka Samu Tsarin Mulki Daga Developasar Ci Gaban. J Trop Pediatr. 2016; 62: 464-470. Duba m.
  40. Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Magungunan rigakafi don rigakafin cututtukan yara masu alaƙa da cututtukan yara. Cochrane Database Syst Rev. 2015;: CD004827. Duba m.
  41. Feizizadeh S, Salehi-Abargouei A, Akbari V. Inganci da amincin Saccharomyces boulardii don cutar gudawa. Ilimin likitan yara. 2014; 134: e176-191. Duba m.
  42. Szajewska H, ​​Horvath A, Kolodziej M. Bincike na yau da kullun tare da meta-bincike: Saccharomyces boulardii kari da kawar da kamuwa da cutar Helicobacter pylori. Aliment Pharmacol Ther. 2015; 41: 1237-1245. Duba m.
  43. Szajewska H, ​​Kolodziej M. Bincike na yau da kullun tare da meta-bincike: Saccharomyces boulardii a cikin rigakafin rigakafin rigakafin-haɗuwa da gudawa. Aliment Pharmacol Ther. 2015; 42: 793-801. Duba m.
  44. Ellouze O, Berthoud V, Mervant M, Parthiot JP, Girard C. Rikicin Septic saboda Sacccaromyces boulardii. Med Mal Mai Cutar. 2016; 46: 104-105. Duba m.
  45. Bafutto M, et al. Jiyya na cututtukan cututtukan hanji tare da mesalamine da / ko Saccharomyces boulardii. Arq Gastroenterol. 2013; 50: 304-309. Duba m.
  46. Bourreille A, et al. Saccharomyces boulardii baya hana sake kamuwa da cutar Crohn. Clin Gastroenterol Hepatol. 2013; 11: 982-987.
  47. Serce O, Gursoy T, Ovali F, Karatekin G. Hanyoyin Saccaromyces boulardii akan neonatal hyperbilirubinemia: gwajin bazuwar sarrafawa. Am J Perinatol. 2015; 30: 137-142. Duba m.
  48. Videlock EJ, Cremonini F. Meta-bincike: maganin rigakafi a cikin cututtukan cututtukan kwayoyin cuta. Aliment Pharmacol Ther. 2012; 35: 1355-69. Duba m.
  49. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. Magungunan rigakafi don rigakafi da magani na cututtukan cututtukan kwayoyin cuta: nazari na yau da kullun da meta-bincike. JAMA. 2012 da 307: 1959-69. Duba m.
  50. Elmer GW, Moyer KA, Vega R, da et al. Bincike na Saccharomyces boulardii ga marasa lafiya da ke fama da cutar kwayar cutar HIV kuma a cikin masu sa kai masu lafiya masu karɓar maganin rigakafi. Microecology Ther 1995; 25: 23-31.
  51. Potts L, Lewis SJ, da Barry R. An ƙaddamar da nazarin makafi guda biyu masu makirci game da ikon Saccharomyces boulardii don hana cututtukan cututtukan kwayoyin cuta [m]. Gut 1996; 38 (samar da 1): A61.
  52. Bleichner G da Blehaut H. Saccharomyces boulardii na hana gudawa a cikin mawuyacin hali marasa lafiyar da ke cikin bututu. Masana da yawa, bazuwar, makauniyar gwajin wuribo mai sau biyu [m]. Clin Nutr 1994; 13 Gudanar da 1:10.
  53. Maupas JL, Champemont P, da Delforge M. [Jiyya na cututtukan hanji tare da Saccharomyces boulardii - makafi biyu, nazarin sarrafa wuribo]. Médicine et Chirurgie Digestives 1983; 12: 77-79.
  54. Saint-Marc T, Blehaut H, Musial C, da et al. [Cutar gudawa da ke da alaƙa da cutar kanjamau: gwaji mai makafi biyu na Saccharomyces boulardii]. Semaine Des Hopitaux 1995; 71 (23-24): 735-741.
  55. McFarland LV, Surawicz C, Greenberg R, da et al. Saccharomyces boulardii da babban maganin vancomycin suna magance cutar Clostridium mai rikitarwa akai-akai [m]. Am J Gastroenterol 1998; 93: 1694.
  56. Chouraqui JP, Dietsch J, Musial C, da et al. Saccharomyces boulardii (SB) a cikin kula da ɗiyar yara gudawa: nazari mai-makafi-wuribo mai sau biyu [m]. J Pediatr Gastroenterol Nutr 1995; 20: 463.
  57. Cetina-Sauri G da Basto GS. Evaluacion terapeutica de Saccharomyces boulardii en ninos con diarrea aguda. Tribuna Med 1989; 56: 111-115.
  58. Adam J, Barret C, Barret-Bellet A, da kuma al. Essais cliniques controles en biyu insu de l’Ultra-Levure Lyophilisee. Etude multicentrique par 25 medecins de 388 cas. Gaz Med Fr 1977; 84: 2072-2078.
  59. McFarland LV, SurawiczCM, Elmer GW, da et al. Bincike iri-iri game da ingancin asibiti na wakili mai maganin cututtukan dabbobi, Saccharomyces boulardii don rigakafin cututtukan da ke tattare da kwayoyin cuta [m]. Am J Epidemiol 1993; 138: 649.
  60. Saint-Marc T, Rossello-Prats L, da Touraine JL. [Ingancin Saccharomyces boulardii a cikin kula da cutar gudawa ta kanjamau]. Ann Med Interne (Paris) 1991; 142: 64-65.
  61. Kirchhelle, A., Fruhwein, N., da Toburen, D. [Maganin cutar gudawa tare da S. boulardii a cikin matafiya masu dawowa. Sakamakon binciken mai yiwuwa]. Madadin Fortschr 4-20-1996; 114: 136-140. Duba m.
  62. Haihuwar, P., Lersch, C., Zimmerhackl, B., da Classen, M. [Maganin Saccharomyces boulardii na cututtukan da ke hade da kwayar cutar kanjamau]. Dtsch Med Wochenschr 5-21-1993; 118: 765. Duba m.
  63. Kollaritsch, H., Holst, H., Grobara, P., da Wiedermann, G. [Rigakafin zawo matafiyi tare da Saccharomyces boulardii. Sakamakon binciken wuribo mai sarrafa ido biyu]. Tsungiyar Fortschr.Med 3-30-1993; 111: 152-156. Duba m.
  64. Tempe, J. D., Steidel, A. L., Blehaut, H., Hasselmann, M., Lutun, P., da Maurier, F. [Rigakafin cutar gudawa da ke bayar da maganin Saccharomyces boulardii yayin ci gaba da ciyarwa cikin jiki]. Sem.Hop. 5-5-1983; 59: 1409-1412. Duba m.
  65. Chapoy, P. [Jiyya na cututtukan cututtukan ƙananan yara: gwajin gwaji na Saccharomyces boulardii]. Ann Pediatr. (Paris) 1985; 32: 561-563. Duba m.
  66. Kimmey, M. B., Elmer, G. W., Surawicz, C. M., da McFarland, L. V. Rigakafin ci gaba da sake faruwa na Clostridium wuya colitis tare da Saccharomyces boulardii. Dig.Dis Sci 1990; 35: 897-901. Duba m.
  67. Saint-Marc, T., Rossello-Prats, L., da Touraine, J. L. [Inganci na Saccharomyces boulardii wajen maganin gudawa a cutar kanjamau]. Ann Med Interne (Paris) 1991; 142: 64-65. Duba m.
  68. Duman, DG, Bor, S., Ozutemiz, O., Sahin, T., Oguz, D., Istan, F., Vural, T., Sandkci, M., Isksal, F., Simsek, I., Soyturk , M., Arslan, S., Sivri, B., Soykan, I., Temizkan, A., Bessk, F., Kaymakoglu, S., da Kalayc, C. Inganci da amincin Saccharomyces boulardii don rigakafin kwayoyin- hade da gudawa saboda kawar da cutar Helicobacterpylori. Eur J Gastroenterol.Hepatol. 2005; 17: 1357-1361. Duba m.
  69. Surawicz, C. M. Jiyya na maimaita Clostridium mai alaƙa da cuta. Nat Clin Pract.Gastroenterol.Hepatol. 2004; 1: 32-38. Duba m.
  70. Kurugol, Z. da Koturoglu, G. Tasirin Saccharomyces boulardii a cikin yara masu fama da zawo. Dokar Paediatr. 2005; 94: 44-47. Duba m.
  71. Kotowska, M., Albrecht, P., da Szajewska, H. Saccharomyces boulardii a cikin rigakafin cututtukan da ke tattare da kwayoyin cuta a cikin yara: gwaji mai saurin rufe wuribo mai-ido biyu. Aliment. Pharmacol.Ther. 3-1-2005; 21: 583-590. Duba m.
  72. Cherifi, S., Robberecht, J., da Miendje, Y. Saccharomyces cerevisiae fungemia a cikin tsofaffi mai haƙuri da Clostridium wuya colitis. Dokar Clin Belg. 2004; 59: 223-224. Duba m.
  73. Erdeve, O., Tiras, U., da Dallar, Y. Sakamakon kwayar cutar Saccharomyces boulardii a cikin rukunin yara na yara. J Trop.Pediatr. 2004; 50: 234-236. Duba m.
  74. Costalos, C., Skouteri, V., Gounaris, A., Sevastiadou, S., Triandafilidou, A., Ekonomidou, C., Kontaxaki, F., da Petrochilou, V. Ciyar da yara ƙanana da basu isa ba tare da Saccharomyces boulardii. Farkon Hum.Dev. 2003; 74: 89-96. Duba m.
  75. Gaon, D., Garcia, H., Winter, L., Rodriguez, N., Quintas, R., Gonzalez, S. N., da Oliver, G. Sakamakon cutar Lactobacillus da Saccharomyces boulardii kan ci gaba da gudawa a cikin yara. Medicina (B Aires) 2003; 63: 293-298. Duba m.
  76. Mansour-Ghanaei, F., Dehbashi, N., Yazdanparast, K., da Shafaghi, A. Inganci na saccharomyces boulardii tare da maganin rigakafi a cikin amoebiasis mai tsanani. Duniya J Gastroenterol. 2003; 9: 1832-1833. Duba m.
  77. Riquelme, A. J., Calvo, M. A., Guzman, A. M., Depix, M. S., Garcia, P., Perez, C., Arrese, M., da Labarca, J. A. Saccharomyces cerevisiae fungemia bayan Saccharomyces boulardii magani a cikin marasa lafiya immunocompromised. J Jarin Gastroenterol. 2003; 36: 41-43. Duba m.
  78. Cremonini, F., Di Caro, S., Santarelli, L., Gabrielli, M., Candelli, M., Nista, EC, Lupascu, A., Gasbarrini, G., da Gasbarrini, A. Probiotics a cikin haɗin kwayoyin gudawa. Yi Digiri. 2002; 34 Gudanar da 2: S78-S80. Duba m.
  79. Lherm, T., Monet, C., Nougiere, B., Soulier, M., Larbi, D., Le Gall, C., Caen, D., da Malbrunot, C. Abubuwa bakwai na fungemia tare da Saccharomyces boulardii a cikin mahimmanci marasa lafiya marasa lafiya. M Kulawa Med 2002; 28: 797-801. Duba m.
  80. Tasteyre, A., Barc, M. C., Karjalainen, T., Bourlioux, P., da Collignon, A. Rashin hana bin ƙwayoyin in vitro bin Clostridium mai wahala ta hanyar Saccharomyces boulardii. Microb.Pathog. 2002; 32: 219-225. Duba m.
  81. Shanahan, F. Probiotics a cikin cututtukan hanji mai kumburi. Gut 2001; 48: 609. Duba m.
  82. Surawicz, CM, McFarland, LV, Greenberg, RN, Rubin, M., Fekety, R., Mulligan, ME, Garcia, RJ, Brandmarker, S., Bowen, K., Borjal, D., da Elmer, GW The bincika mafi kyawun magani don sake kamuwa da cutar Clostridium mai wahala: amfani da babban ƙwayar vancomycin haɗe tare da Saccharomyces boulardii. Clin.Infect.Dis. 2000; 31: 1012-1017. Duba m.
  83. Johnston BC, Ma SSY, Goldenberg JZ, et al. Magungunan rigakafi don rigakafin cututtukan da ke hade da Clostridium mai wahala. Ann Intern Med 2012; 157: 878-8. Duba m.
  84. Munoz P, Bouza E, Cuenca-Estrella M, et al. Saccharomyces cerevisiae fungemia: cuta mai saurin yaduwa. Clin Infect Dis 2005; 40: 1625-34. Duba m.
  85. Szajewska H, ​​Mrukowicz J. Meta-analysis: yisti maras cutarwa Saccharomyces boulardii a cikin rigakafin cututtukan cututtukan kwayoyin cuta. Aliment Pharmacol Ther 2005; 22: 365-72. Duba m.
  86. Za a iya M, Besirbellioglu BA, Avci IY, et al. Prophylactic Saccharomyces boulardii a cikin rigakafin cututtukan cututtukan kwayoyin cuta: Nazarin mai yiwuwa. Med Sci Monit 2006; 12: PI19-22. Duba m.
  87. Guslandi M, Giollo P, Testoni PA. Gwajin gwaji na Saccharomyces boulardii a cikin ciwon ulcerative colitis. Eur J Gastroenterol Hepatol 2003; 15: 697-8. Duba m.
  88. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii don kula da cutar Crohn. Dig Dis Sci 2000; 45: 1462-4. Duba m.
  89. McFarland LV. Meta-bincike na maganin rigakafi don rigakafin cututtukan cututtukan kwayoyin da ke hade da cutar Clostridium mai wahala. Am J Gastroenterol 2006; 101: 812-22. Duba m.
  90. Marteau P, Seksik P. Haƙuri na maganin rigakafi da prebiotics. J Jarin Gastroenterol 2004; 38: S67-9. Duba m.
  91. Borriello SP, Hammes WP, Holzapfel W, et al. Amincin maganin rigakafi wanda ya ƙunshi lactobacilli ko bifidobacteria. Clin Infect Dis 2003; 36: 775-80. Duba m.
  92. Cremonini F, Di Caro S, Covino M, et al. Hanyoyin shirye-shiryen maganin rigakafi daban-daban akan cututtukan cututtukan da ke tattare da maganin hawan-kumburi: haɗuwa da rukuni guda, makafi sau uku, binciken sarrafa wuribo. Am J Gastroenterol 2002; 97: 2744-9. Duba m.
  93. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Magungunan rigakafi a cikin rigakafin cututtukan cututtukan cututtukan kwayoyin cuta: meta-bincike. BMJ 2002; 324: 1361. Duba m.
  94. Muller J, Remus N, Harms KH. Nazarin mycoserological na maganin marasa lafiyar yara cystic fibrosis tare da Saccharomyces boulardii (Saccharomyces cerevisiae Hansen CBS 5926). Magunguna 1995; 38: 119-23. Duba m.
  95. Plein K, Hotz J. Magungunan warkewa na Saccharomyces boulardii akan alamomin alamomi masu rauni a cikin yanayin kwanciyar hankali na cutar Crohn tare da girmamawa ta musamman ga cutar gudawa - binciken matukin jirgi. Z Gastroenterol 1993; 31: 129-34. Duba m.
  96. Hennequin C, Thierry A, Richard GF, et al. Bugun Microsatellite a matsayin sabon kayan aiki don gano matsalolin Saccharomyces cerevisiae. J Jarin Microbiol 2001; 39: 551-9. Duba m.
  97. Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia a cikin mai haƙuri wanda aka kula da shi tare da Saccharomyces boulardii. Tallafin Ciwon Kula da Lafiya 2000; 8: 504-5. Duba m.
  98. Weber G, Adamczyk A, Freytag S. [Maganin kuraje tare da shirya yisti]. Kamfanin Fortschr Med 1989; 107: 563-6. Duba m.
  99. Lewis SJ, Freedman AR. Bayanin sake dubawa: amfani da jami'ai masu amfani da maganin rigakafi da maganin cututtukan ciki. Aliment Pharmacol Ther 1998; 12: 807-22. Duba m.
  100. Krammer M, Karbach U. Ayyukan ɓarna na yisti Saccharomyces boulardii a cikin ƙananan ƙanana da babban hanji ta hanyar motsa ƙarfin chloride. Z Gastroenterol 1993; 31: 73-7.
  101. Czerucka D, Roux I, Rampal P. Saccharomyces boulardii ya hana adenosine 3 ’, 5’-cyclic monophosphate shigar a cikin kwayayen hanji. Gastroenterol 1994; 106: 65-72. Duba m.
  102. Elmer GW, McFarland LV, Surawicz CM, et al. Halin Saccharomyces boulardii a cikin marasa lafiyar Clostridium mai wahala. Aliment Pharmacol Ther 1999; 13: 1663-8. Duba m.
  103. Fredenucci I, Chomarat M, Boucaud C, et al. Saccharomyces boulardii fungemia a cikin majiyyacin da ke karbar magani mai sauki. Clin Infect Dis 1998; 27: 222-3.Duba m.
  104. Pletinex M, Legein J, Vandenplas Y. Fungemia tare da Saccharomyces boulardii a cikin yarinya 'yar shekara 1 mai fama da zawo. J Pediatr Gastroenterol Nutr 1995; 21: 113-5. Duba m.
  105. Buts JP, Corthier G, Delmee M. Saccharomyces boulardii don Clostridium masu haɗarin haɗakar ƙwayoyin cuta a cikin jarirai. J Pediatr Gastroenterol Nutr 1993; 16: 419-25. Duba m.
  106. Surawicz CM, Elmer GW, Speelman P, et al. Rigakafin cututtukan cututtukan kwayoyin cuta ta hanyar Saccharomyces boulardii: nazari mai yiwuwa. Gastroenterology 1989; 96: 981-8. Duba m.
  107. Surawicz CM, McFarland LV, Elmer G, et al. Jiyya na maƙogwaron ƙwayar cuta mai saurin dawowa tare da vancomycin da Saccharomyces boulardii. Am J Gastroenterol 1989; 84: 1285-7. Duba m.
  108. McFarland LV, Surawicz CM, Greenberg RN, et al. Rigakafin cututtukan beta-lactam da ke haɗuwa da cutar Saccharomyces boulardii idan aka kwatanta da placebo. Am J Gastroenterol 1995; 90: 439-48. Duba m.
  109. McFarland LV, Surawicz CM, Greenberg RN, et al. Gwajin gwajin wuribo da bazuwar Saccharomyces boulardii a hade tare da daidaitaccen maganin rigakafin cuta na Clostridium. JAMA 1994; 271: 1913-8. Duba m.
  110. Elmer GW, McFarland LV. Sharhi game da rashin tasirin magani na Saccharomyces boulardii a cikin rigakafin cutar gudawa da ke da alaƙa da kwayoyin cuta a cikin tsofaffi marasa lafiya. J Cutar 1998; 37: 307-8. Duba m.
  111. Lewis SJ, Potts LF, Barry RE. Rashin tasirin magani na Saccharomyces boulardii a cikin rigakafin cutar gudawa da ke da alaƙa da kwayoyin cuta a cikin tsofaffi marasa lafiya. J Cutar 1998; 36: 171-4. Duba m.
  112. Bleichner G, Blehaut H, Mentec H, et al. Saccharomyces boulardii na hana gudawa a cikin majinyacin rashin lafiyar da ke fama da cutar bututu. M Kulawa Med 1997; 23: 517-23. Duba m.
  113. Castagliuolo I, Riegler MF, Valenick L, et al. Saccharomyces boulardii protease yana hana sakamakon toxins masu wuya na A da B a cikin ƙwayar jikin mutum. Kamuwa da cuta da rigakafi 1999; 67: 302-7. Duba m.
  114. Saavedra J. Probiotics da cututtukan cututtuka. Am J Gastroenterol 2000; 95: S16-8. Duba m.
  115. McFarland LV. Saccharomyces boulardii ba shine Saccharomyces cerevisiae ba. Clin Infect Dis 1996; 22: 200-1. Duba m.
  116. McCullough MJ, Clemons KV, McCusker JH, Stevens DA. Gano nau'ikan halittu da halayen kwayar cutar Saccharomyces boulardii (nom. Inval.). J Jarin Microbiol 1998; 36: 2613-7. Duba m.
  117. Niault M, Thomas F, Kayan J, et al. Fungemia saboda nau'in Saccharomyces a cikin majiyyacin da aka kula da shi tare da cutar Saccharomyces boulardii. Clin Infect Dis 1999; 28: 930. Duba m.
  118. Bassetti S, Frei R, Zimmerli W. Fungemia tare da Saccharomyces cerevisiae bayan jiyya tare da Saccharomyces boulardii. Am J Med 1998; 105: 71-2. Duba m.
  119. Scarpignato C, Rampal P. Rigakafin da maganin zawo na matafiyi: Hanyar likitancin asibiti. Chemotherapy 1995; 41: 48-81. Duba m.
Binciken na ƙarshe - 11/10/2020

Mashahuri A Kan Shafin

Menene Leukocytosis?
Kiwon Lafiya

Menene Leukocytosis?

BayaniLeukocyte wani una ne na farin jini (WBC). Waɗannan u ne ƙwayoyin jininku waɗanda ke taimaka wa jikinku yaƙar cututtuka da wa u cututtuka.Lokacin da yawan fararen ƙwayoyin halitta a cikin jinin...
Menene Matsakaicin Matsakaicin Gudu kuma Shin Kuna Iya Inganta Saurin Ku?
Kiwon Lafiya

Menene Matsakaicin Matsakaicin Gudu kuma Shin Kuna Iya Inganta Saurin Ku?

Mat akaicin guduMat akaicin gudu, ko aurin, ya dogara da dalilai da yawa. Waɗannan un haɗa da matakin dacewa na yanzu da halittar jini. A hekarar 2015, trava, wata ka a da ka a mai aikin t eren keke ...